Polyaniline decorated TiO2 nanoparticles were successfully synthesized in situ by chemical oxidative polymerization. The FT-IR and XRD results proved the strong interfacial interaction between the TiO2 nanoparticles and the polyaniline chain. It is confirmed that the diameter of the resulted PANI-TiO2 nanoparticles is about 70 nm and the interactions between the two components are strong.
An efficient and environment friendly methodology for the synthesis of 3,4-dihydropyrimidin-2-(1H)-ones/thiones using polyaniline-TiO2 nanocomposite as a heterogeneous catalyst. The present protocol is superior in terms of scope for the synthesis of dihydropyrimidinones and thiones, offers several notable advantages over the existing methods, including ease in handling, reusability, thermal stability, environmentally friendly, short reaction times, and operational simplicity.
Table 1
Polyaniline – TiO2 promoted synthesis of dihydropyrimidinones and thiones under solvent free condition
Entry | Product | Aldehyde R | X | Ultrasound | M.P. |
Time (min) | Yield (%) |
1 | 4a | C6H5 | O | 45 | 92 (78)b | 202–205 |
2 | 4b | Ph CH = CH | O | 35 | 95 | 230–236 |
3 | 4c | 4-NO2-C6H5 | O | 60 | 87 (58)b | 234–236 |
4 | 4d | 4 NMe2C6H4 | O | 35 | 92 (86)b | 256–258 |
5 | 4e | 4 Cl-C6H4 | O | 47 | 87 (56)b | 211–213 |
6 | 4f | C6H5 | S | 42 | 88 | 203–205 |
7 | 4g | PhCH = CH | S | 43 | 86 | 227–230 |
8 | 4h | 4-NO2-C6H5 | S | 65 | 89 | 153–155 |
9 | 4i | 4 NMe2C6H4 | S | 40 | 90 | 230–233 |
10 | 4j | 4 Cl-C6H4 | S | 50 | 86 | 193–194 |
All products were characterized by IR, 1H NMR and LCMS
a Polyaniline -TiO2 promoted synthesis of DHPM
b Conventional methods of synthesis of DHPM (cat HCl in EtOH, reflux, 18 h)
Spectral data of selected compounds:
1) 5-Ethoxycarbonyl-6-methyl-4-phenyl-3, 4-dihydropyrimidin-2(1H)-one (4a):
1H NMR (400 MHz, CDCl3) δ: 1.10 (t, 3H, J=6.88 Hz, OCH2CH3), 2.24 (s, 3H, CH3), 4.06 (q, 2H, J=6.88 Hz, OCH2CH3), 5.12 (s, 1H, C(4)-H), 7.26-7.30 (m, 5H, C6H5), 7.82 (s, 1H, NH), 9.11 (s, 1H, NH); MS (m/e): 261(M+1), 260 (M+); IR (KBr) cm-1: 3242, 3115, 1726, 1647, 1600, 1419, 1311, 1091, 783.
2) 5-Ethoxycarbonyl-6-methyl-4-cinnamyl-3,4-dihydropyrimidin-2(1H)-one (4b):
1H NMR (400 MHz, DMSO-d6) δ: 1.20 (t, 3H, OCH2CH3), 2.23 (s, 3H, vinyl methyl), 4.10 (q, 2H, OCH2CH3), 4.85 (d, 1H, C(4) -H), 6.2 (d, 1H, CH=CH), 6.4 (d, 1H, CH=CH), 7.2 (m, 5H, Ar-H), 9.5 (bs, 1H, NH), 10.2 (bs, 1H, NH). MS (m/e): 287(M+1); IR (KBr) cm-1: 3115, 3039, 1710, 1678, 1615, 1250, 750.
3) 5-Ethoxycarbonyl-4-(4-nitro-phenyl)-6-methyl-3,4-dihydropyrimidin-2(1H)-one (4c):
1H NMR (400 MHz, CDCl3) δ:1.1 (t, 3H, OCH2CH3), 2.27 (s, 3H, CH3), 3.98 (q, 2H, OCH2CH3), 5.30 (d, 1H, C(4)-H), 7.51 (d, 2H, Ar-H), 7.89 (s, 1H, NH), 8.22 (d, 2H, Ar-H), 9.37 (s, 1H, NH); MS (m/e): 306 (M+1); IR (KBr) cm-1: 3224, 2950, 1745, 1670, 1510, 1340, 1125, 780
4) 5-Ethoxycarbonyl-4-(4-N(CH3)2)l-6-methyl-dihydropyrimidin-2(1H)-one (4d):
1H NMR (400 MHz, DMSO-d6) δ: 1.18 (t, 3H, J=7.6 Hz, CH3), 2.4 (s, 3H, CH3), 2.8 (s, 6H, N(CH3)2), 4.00 (q, 2H, J=7.6 Hz, OCH2CH3), 5.02 (d, 1H, C(4)-H), 6.6 (d, 2H, J=9.1 Hz, Ar-H), 7.00 (d, 2H, J=9.1 Hz, Ar-H), 7.6 and 9.16 (2 bs, 2H, NH); MS (m/e): 304 (M+1); IR (KBr) cm−1: 3200, 3100, 1700, 1685.
5) 5-Ethoxycarbonyl-4-(4-chlorophenyl)-6-methyl-3,4-dihydropyrimidin-2(1H)-one (4e):
1H NMR (400 MHz, DMSO-d6) δ: 1.12 (t, 3H, J=7.14 Hz, OCH2CH3), 2.30 (s, 3H, CH3), 3.91 (q, 2H, J=7.16 Hz, OCH2CH3), 5.07 (d, 1H, J=2.28, CH), 7.21 (d, 2H, J=9.18, Ar-H), 7.69 (d, 2H, J=9.18, Ar-H), 7.94(s, 1H, NH), 9.29 (bs, 1H, NH); MS (m/e): 295 (M+1); IR (KBr) cm-1: 3225, 1720, 1615.
6) 5-Ethoxycarbonyl-4-(4-chlorophenyl)-6-methyl-3, 4-dihydropyrimidin-2(1H)-one (4f):
1HNMR (DMSO-d6) δ: 1.12 (t, 3H, J = 7.14 Hz, -OCH2CH3), 2.30 (s, 3H, -CH3), 3.91 (q, 2H, J=7.16 Hz,- OCH2CH3), 5.70 (d, 1H, J = 2.28, -CH), 7.21 (d, 2H, J = 9.18, Ar-H), 7.69 (s, 1H, -NH),7.94 (d, 2H, J = 9.18, Ar-H), 9.16 (s, 1H, -NH). MS (m/e): 297 (M+1);IR (KBr, cm-1): IR (KBr, cm-1): 3225, 1720, 1615.
7) 5-Ethoxycarbonyl-4-(4-phenyl)-6-methyl-3, 4-dihydropyrimidin-2(1H)-thione(4g):
1H NMR (DMSO-d6): δ 1.19 (t, J=7.3 Hz, 3H, CH3), 2.27 (s, 3H, CH3), 4.08 (q, J=7.3Hz, 2H, -OCH2), 5.22 (s, 1H, CH), 7.23 (m, 5H, Ar), 9.25 and 9.9 (2s, 2H,2brs. NH); MS (m/e): (M+1) 293; IR (KBr, cm-1): 3244, 3115, 1727, 1647, 1600, 1419, 1311, 1091, 783.
8) 5-Ethoxycarbonyl-4-(4-nitrophenyl)-6-methyl-3,4-dihydropyrimidin-2(1H)-thione (4h):
1H NMR (DMSOd6): δ 1.13 (t, 3H, CH3-CH2O), 2.31 (s, 3H, -CH3), 3.99 (q, 2H, -OCH2), 5.22 (s, 1H, CH), 7.56 (d, 2H, ArH), 7.90 (s, 1H,- NH), 8.11 (d, 2H, ArH), 9.39 (s, 1H, NH)
MS: (M+1);338); IR (KBr) cm-1: 3226, 2950, 1745, 1670, 1510, 1340, 1127, 782.
9) 5-Ethoxycarbonyl-4-(4-N(CH3)2)l-6-methyl-3,4-dihydropyrimidin-2(1H)-thione (4i):
1H NMR (400 MHz, DMSO-d6) δ: 1.20 (t, 3H, J=7.6 Hz, CH3), 2.25 (s, 3H, CH3), 2.87 (s, 6H, N(CH3)2), 4.00 (q, 2H, J=7.6 Hz, OCH2), 5.18 (d, 1H, C(4)-H), 6.62 (d, 2H, J=9.1 Hz, Ar-H), 7.19 (d, 2H, J=9.1 Hz, Ar-H), 9.80 (bs, 1H, NH), 10.2 (bs, 1H, NH); MS (m/e): 320 (M+1); IR (KBr) cm-1: 3196, 1640, 1552, 1475, 1191.
10) 5-Ethoxycarbonyl-4-(4-chlorophenyl)-6-methyl-3,4-dihydropyrimidin-2(1H)-thione (4j)
1HNMR (DMSO-d6) δ: 1.10 (t,3H, J =7.01 Hz, -OCH2CH3), 2.29(s, 3H, -CH3), 2.26 (3H,s, -CH3) 4.00 (q, 2H, J=7.01 Hz,- OCH2CH3), 5.16 (d, 1H, -C(4)H), 7.22(d, 2H, J = 7.04 Hz, Ar-H), 7.43 (d, 2H, J = 7.04 Hz, Ar-H), 10.40 (br s, 1H, -NH),9.68 (br s, 1H, -NH).MS:m/e (M+1) 311 ((M+1) IR (KBr) cm-1: 3225, 1720, 1615.